1219741-53-3 Usage
Chemical structure
A complex chemical compound with an indole ring and a boron-containing substituent.
Indole ring
Contains an indole ring, which is a common structural motif found in many biologically active compounds.
Ethyl group
Has an ethyl group at the 1-position of the indole ring.
Boron-containing substituent
Contains a 4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl group at the 5-position of the indole ring.
Boron-containing heterocycle
The boron substituent is a boron-containing heterocycle.
Potential applications
May have potential applications in organic synthesis, as boron-containing compounds are often used as reagents and catalysts in various chemical reactions.
Medicinal chemistry
May be of interest for research purposes in medicinal chemistry due to the presence of the indole ring.
Further studies needed
Further studies would be needed to determine the specific properties and potential uses of this compound.
Please note that this list is based on the information provided and may not be exhaustive. Additional research and analysis would be required to fully understand the properties and potential applications of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1219741-53-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,7,4 and 1 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1219741-53:
(9*1)+(8*2)+(7*1)+(6*9)+(5*7)+(4*4)+(3*1)+(2*5)+(1*3)=153
153 % 10 = 3
So 1219741-53-3 is a valid CAS Registry Number.
1219741-53-3Relevant articles and documents
NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS
-
Page/Page column 43, (2010/04/25)
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.
NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS
-
Page/Page column 89, (2010/05/14)
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK- activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.
